Under construction – not a live service
Sign in
Taking people in CanadaPhase 4

Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Key facts

Where
Winnipeg, CanadaSee the site
Phase
Phase 4

Where in Canada

  • University of ManitobaWinnipeg, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Manitoba
Trial code
NCT06298461
Record updated
8 January 2025
Original description
The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).Read full original descriptionShow less

Bowel Preparation for Colonoscopy Among Individuals With IBD: A Randomized Controlled Trial

The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).

Inclusion: Crohn's disease or ulcerative colitis patients scheduled or about to be scheduled for colonoscopy; Age > 18 years; Out-patients.

Exclusion: Prior subtotal or total colorectal resection; Contraindications to use of 2L polyethylene glycol (2L-PEG) or Oral Sulfate Solution (OSS): Known renal insufficiency, congestive heart failure, cirrhosis, severe electrolyte imbalance; Allergies to the employed bowel preparations; IBD patients thought to be too sick to undergo a full colonoscopy preparation in the opinion of the investigator/treating physician; hospitalized crohn's disease or ulcerative colitis patients; Colonoscopy being repeated because of poor preparation in the preceding six months; Toxic megacolon, ileus, suspected or diagnosed bowel obstruction; Pregnancy.

ClinicalTrials.gov NCT06298461